Quantcast
Last updated on April 24, 2014 at 6:45 EDT

Latest Clinical research Stories

2014-03-14 04:20:45

REYKJAVIK, Iceland, March 14, 2014 /PRNewswire/ -- Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. ("Finesse"), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient manufacturing and laboratory technology through the Finesse turnkey SmartFactory® GMP manufacturing platform suite. SmartFactory® is a single-use cGMP bio-manufacturing capacity, which...

2014-03-13 23:27:22

JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company’s Investigational New Drug (IND) to conduct an initial Phase 3 clinical trial of JDP-205 in patients with acute urticaria associated with an acute allergic reaction has been cleared by the U.S. Food and Drug Administration (FDA). Blue Bell, PA (PRWEB) March 13, 2014 JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the...

2014-03-13 23:03:24

FDNA will unveil Face2Gene™, a mobile app for research and investigation of genetic syndromes, using facial photos. (PRWEB) March 13, 2014 FDNA® (http://www.fdna.com) – a pioneer in computer-aided dysmorphology analysis is scheduled to exhibit at the 2014 ACMG meeting, booth #915 in Nashville, Tennessee. The company will present its proprietary technology in a scheduled theater presentation and unveil Face2Gene, the first available search and reference mobile application, powered...

2014-03-13 20:24:12

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/drlfwg/new_eu) have announced the addition of the "New EU Pharmacovigilance Legislation - The Complete Picture (Course, London)" [http://www.researchandmarkets.com/research/drlfwg/new_eu ] conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The New EU Pharmacovigilance Legislation - The Complete Picture Course will be held...

2014-03-13 20:23:07

DUBLIN, Ireland, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4jfvgp/regulatory ) has announced the addition of the "Regulatory Affairs For Support Staff (Course, London)" [http://www.researchandmarkets.com/research/4jfvgp/regulatory ] conference to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Regulatory Affairs For Support Staff course will be held on the...

2014-03-13 17:18:53

Investigators call on drug regulators to provide clear evidence to patients on claims of drug side effects At a time when the wider prescription of statins is under renewed public scrutiny, a substantial analysis of placebo-controlled randomised trials of statins has found that only a small minority of side effects reported by those taking the cholesterol-lowering drugs are actually attributable to them. Almost all the side effects reported in these trials "occurred anyway when patients...

2014-03-13 17:09:31

'No robust, consistent evidence to show home care visits provide benefit to the elderly' In what's thought to be the biggest review of academic literature into whether home care visits provide benefits for the elderly, researchers conclude there is 'no consistent evidence' to show they lead to the elderly living longer or having more independent lives than those without any visits. Researchers from University College London (UCL) and the University of Oxford analyzed 64 randomized...

Are Your Pets Benefiting From Their Pain Medication?
2014-03-13 15:17:15

Tracey Peake, North Carolina State University How do you know that your pet is benefiting from its pain medication? A new clinical trial design could help overcome pet owners’ unconscious observation bias and determine whether the drugs they test are effective. When animals are recruited for clinical trials, particularly for pain medications, researchers must rely on owner observation to determine whether the medication is working. Sounds simple enough, but as it turns out, human and...

2014-03-13 12:29:30

New Asian Bridging Clinical Research Unit has been opened by Contract Research Organization WCCT Global COSTA MESA, Calif., March 13, 2014 /PRNewswire-iReach/ -- WCCT Global, a full service CRO headquartered in Southern California announced today the opening of a new Asian Bridging clinical research site. This state of the art facility has been reconfigured to provide for 30 semi-private rooms to give each clinical trial volunteer a more comfortable experience for extended in-house...

2014-03-13 04:23:04

TAIPEI, March 13, 2014 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced that the Taiwan Food and Drug Administration (TFDA) has approved the new drug application (NDA) of Taigexyn(® )(nemonoxacin) oral formulation (500 mg) for the treatment of community-acquired bacterial pneumonia (CAP). With this NDA approval, Taiwan is the first region to grant marketing approval to Taigexyn(®). An NDA for Taigexyn(® ) was also submitted to China FDA (CFDA) in...